#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma Encephalopathy neonatal Ewing's sarcoma metastatic Hypotransferrinaemia Interstitial lung disease Chronic graft versus host disease in intestine Renal disorder Henoch-Schonlein purpura nephritis Extra-osseous Ewing's sarcoma Breast angiosarcoma Cluster headache Immune-mediated myositis Skin cancer Mitochondrial encephalomyopathy Porphyria non-acute More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Treatment Gaucher’s disease type III – Life with Disease Rhabdomyosarcoma recurrent – Diagnostics Combined immunodeficiency – Trials in Disease Ewing’s sarcoma recurrent – Life with Disease Factor VIII deficiency – Trials in Disease Skin angiosarcoma – Life with Disease Choroid melanoma – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Acute respiratory distress syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-35B-116 Etrumadenant Sar444656 Somatostatin Denosumab Omeprazole Plitidepsin Nms-03592088 ISPAGHULA HUSK Oxytocin Tramadol NAVENIBART Autologous Pancreatic Islets Narsoplimab Linerixibat Mitoxantrone Pyruvic Acid Glenzocimab Human Immunoglobulin G Ripretinib More therapies…

    Learn about Your Condition

    Bladder cancer recurrent Cognitive disorder Genitourinary tract neoplasm Alveolar proteinosis Erectile dysfunction Adenocarcinoma pancreas Cutaneous lupus erythematosus Abdominal wall pain Metastatic neoplasm Dent's disease Glomerulonephritis acute Colon cancer stage IV Dermatitis Myotonia Diffuse large B-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic foot

  • Evaluating the effect of semaglutide on wound healing in patients with diabetic foot ulcers

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study on the Effect of Semaglutide on Healing Foot Ulcers in Patients with Type 2 Diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on the Effects of Autologous Bone Marrow-Derived Mononuclear Cells for Patients with Diabetic Foot Syndrome and Lower Limb Ischemia

    Recruiting

    4 1 1
    Investigated Diseases:
    • Diabetic foot
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR CELLS
    Czechia

  • Study on the Safety and Effectiveness of Allogenic Stem Cells for Treating Diabetic Foot Ulcers in Patients with Diabetes

    Recruiting

    2 1
    Poland

  • Treatment Study of Diabetic Foot Ulcers Using Autologous Stromal Vascular Fraction Cells for Patients with Non-healing Wounds

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    France

  • Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Hypochlorite
    Sweden
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!